Industry reports
Editor highlights

Search inside this page

Free Market Research Guides to Download

Global Pathology Analysis & Statistics, February 2014 (p2)

You might be interested in: cancer, breast cancer, prostate cancer, more »

» Purchase Premium Reports

31-80 of about 2 900 reports
Latuda (Schizophrenia) - Forecast and Market Analysis to 2022

Latuda (Schizophrenia) - Forecast and Market Analysis to 2022

  • $ 3 495
  • Industry report
  • February 2014
  • by Global Data

Latuda (Schizophrenia) - Forecast and Market Analysis to 2022 Summary Schizophrenia is a persistent long-term brain disorder that causes severe, debilitating psychotic episodes. Its core symptoms, auditory ...

  • Industries : Pathology
  • Countries : Spain, Italy, France, Germany, Japan, World, United States, United Kingdom, Europe
Zyprexa (Schizophrenia) - Forecast and Market Analysis to 2022

Zyprexa (Schizophrenia) - Forecast and Market Analysis to 2022

  • $ 3 495
  • Industry report
  • February 2014
  • by Global Data

Zyprexa (Schizophrenia) - Forecast and Market Analysis to 2022 Summary Schizophrenia is a persistent long-term brain disorder that causes severe, debilitating psychotic episodes. Its core symptoms, auditory ...

  • Industries : Pathology
  • Countries : Spain, Italy, France, Germany, Japan, World, United States, United Kingdom, Europe
Invega (Schizophrenia) - Forecast and Market Analysis to 2022

Invega (Schizophrenia) - Forecast and Market Analysis to 2022

  • $ 3 495
  • Industry report
  • February 2014
  • by Global Data

Invega (Schizophrenia) - Forecast and Market Analysis to 2022 Summary Schizophrenia is a persistent long-term brain disorder that causes severe, debilitating psychotic episodes. Its core symptoms, auditory ...

  • Industries : Pathology
  • Countries : Spain, Italy, France, Germany, Japan, World, United States, United Kingdom, Europe
Prochymal (Crohn's Disease) - Forecast and Market Analysis to 2022

Prochymal (Crohn's Disease) - Forecast and Market Analysis to 2022

  • $ 3 495
  • Industry report
  • January 2014
  • by Global Data

Prochymal (Crohn's Disease) - Forecast and Market Analysis to 2022 Summary The Crohn's disease (CD) market is currently very dynamic, with novel biologic therapies on the horizon. These compounds will ...

  • Industries : Pathology
  • Countries : Canada, World, United States, India, China
Stelara (Crohn's Disease) - Forecast and Market Analysis to 2022

Stelara (Crohn's Disease) - Forecast and Market Analysis to 2022

  • $ 3 495
  • Industry report
  • January 2014
  • by Global Data

Stelara (Crohn's Disease) - Forecast and Market Analysis to 2022 Summary The Crohn's disease (CD) market is currently very dynamic, with novel biologic therapies on the horizon. These compounds will challenge ...

  • Industries : Pathology
  • Countries : Canada, World, Spain, Italy, France, Germany, Japan, United States, United Kingdom, India, China, Europe
Tysabri (Crohn's Disease) - Forecast and Market Analysis to 2022

Tysabri (Crohn's Disease) - Forecast and Market Analysis to 2022

  • $ 3 495
  • Industry report
  • January 2014
  • by Global Data

Tysabri (Crohn's Disease) - Forecast and Market Analysis to 2022 Summary The Crohn's disease (CD) market is currently very dynamic, with novel biologic therapies on the horizon. These compounds will challenge ...

  • Industries : Pathology
  • Countries : China, World, Spain, Italy, France, Germany, United States, Canada, India, Europe
Vercirnon (Crohn's Disease) - Forecast and Market Analysis to 2022

Vercirnon (Crohn's Disease) - Forecast and Market Analysis to 2022

  • $ 3 495
  • Industry report
  • January 2014
  • by Global Data

Vercirnon (Crohn's Disease) - Forecast and Market Analysis to 2022 Summary The Crohn's disease (CD) market is currently very dynamic, with novel biologic therapies on the horizon. These compounds will ...

  • Industries : Pathology
  • Countries : Canada, World, Spain, Italy, France, Germany, United States, United Kingdom, India, China, Europe
PharmaPoint: Migraine - Current and Future Players

PharmaPoint: Migraine - Current and Future Players

  • $ 2 995
  • Industry report
  • March 2014
  • by Global Data

PharmaPoint: Migraine - Current and Future Players Summary GlobalData has released its pharma report, “PharmaPoint: Migraine - Current and Future Players”. The report is a vital source of up-to-date ...

  • Industries : Pathology
  • Countries : World
PharmaPoint: Schizophrenia - Current and Future Players

PharmaPoint: Schizophrenia - Current and Future Players

  • $ 2 995
  • Industry report
  • February 2014
  • by Global Data

PharmaPoint: Schizophrenia - Current and Future Players Summary GlobalData has released its pharma report, “PharmaPoint: Schizophrenia - Current and Future Players”. The report is a vital source of ...

  • Industries : Pathology
  • Countries : World
PharmaPoint: Crohn's Disease - Current and Future Players

PharmaPoint: Crohn's Disease - Current and Future Players

  • $ 2 995
  • Industry report
  • January 2014
  • by Global Data

PharmaPoint: Crohn's Disease - Current and Future Players Summary GlobalData has released its pharma report, “PharmaPoint: Crohn's Disease - Current and Future Players”. The report is a vital source ...

  • Industries : Pathology
  • Countries : World
Refractory Acute Myeloid Leukemia Global Clinical Trials Review, H1, 2014

Refractory Acute Myeloid Leukemia Global Clinical Trials Review, H1, 2014

  • $ 2 500
  • Industry report
  • April 2014
  • by Global Data

Refractory Acute Myeloid Leukemia Global Clinical Trials Review, H1, 2014 Summary GlobalData's clinical trial report, “Refractory Acute Myeloid Leukemia Global Clinical Trials Review, H1, 2014" provides ...

  • Industries : Pathology
  • Countries : World
Metastatic Renal Cell Carcinoma Global Clinical Trials Review, H1, 2014

Metastatic Renal Cell Carcinoma Global Clinical Trials Review, H1, 2014

  • $ 2 500
  • Industry report
  • April 2014
  • by Global Data

Metastatic Renal Cell Carcinoma Global Clinical Trials Review, H1, 2014 Summary GlobalData's clinical trial report, “Metastatic Renal Cell Carcinoma Global Clinical Trials Review, H1, 2014" provides ...

  • Industries : Pathology
  • Countries : World
Global Hernia Repair Devices Market 2014-2018

Global Hernia Repair Devices Market 2014-2018

  • $ 2 500
  • Industry report
  • April 2014
  • by Infiniti Research Limited

About Hernias A hernia is condition in which a tissue, organ or fascia of the organ protrudes through the wall of a weak muscle area. Obesity, poor nutrition, smoking, and a weak muscle area at birth ...

  • Industries : Pathology
  • Countries : World
Metastatic Breast Cancer Global Clinical Trials Review, H1, 2014

Metastatic Breast Cancer Global Clinical Trials Review, H1, 2014

  • $ 2 500
  • Industry report
  • March 2014
  • by Global Data

Metastatic Breast Cancer Global Clinical Trials Review, H1, 2014 Summary GlobalData's clinical trial report, “Metastatic Breast Cancer Global Clinical Trials Review, H1, 2014" provides data on the Metastatic ...

  • Industries : Pathology
  • Countries : World
B-Cell Non-Hodgkin Lymphoma Global Clinical Trials Review, H1, 2014

B-Cell Non-Hodgkin Lymphoma Global Clinical Trials Review, H1, 2014

  • $ 2 500
  • Industry report
  • March 2014
  • by Global Data

B-Cell Non-Hodgkin Lymphoma Global Clinical Trials Review, H1, 2014 Summary GlobalData's clinical trial report, “B-Cell Non-Hodgkin Lymphoma Global Clinical Trials Review, H1, 2014" provides data on ...

  • Industries : Pathology
  • Countries : World
Papillary Renal Cell Carcinoma Global Clinical Trials Review, H1, 2014

Papillary Renal Cell Carcinoma Global Clinical Trials Review, H1, 2014

  • $ 2 500
  • Industry report
  • March 2014
  • by Global Data

Papillary Renal Cell Carcinoma Global Clinical Trials Review, H1, 2014 Summary GlobalData's clinical trial report, “Papillary Renal Cell Carcinoma Global Clinical Trials Review, H1, 2014" provides data ...

  • Industries : Pathology
  • Countries : World
Malignant Fibrous Histiocytoma Of Bone Global Clinical Trials Review, H1, 2014

Malignant Fibrous Histiocytoma Of Bone Global Clinical Trials Review, H1, 2014

  • $ 2 500
  • Industry report
  • March 2014
  • by Global Data

Malignant Fibrous Histiocytoma Of Bone Global Clinical Trials Review, H1, 2014 Summary GlobalData's clinical trial report, “Malignant Fibrous Histiocytoma Of Bone Global Clinical Trials Review, H1, 2014" ...

  • Industries : Pathology
  • Countries : World
Papillary Thyroid Cancer Global Clinical Trials Review, H1, 2014

Papillary Thyroid Cancer Global Clinical Trials Review, H1, 2014

  • $ 2 500
  • Industry report
  • March 2014
  • by Global Data

Papillary Thyroid Cancer Global Clinical Trials Review, H1, 2014 Summary GlobalData's clinical trial report, “Papillary Thyroid Cancer Global Clinical Trials Review, H1, 2014" provides data on the Papillary ...

  • Industries : Pathology
  • Countries : World, United States
Global Diabetic Nephropathy Market 2014-2018

Global Diabetic Nephropathy Market 2014-2018

  • $ 2 500
  • Industry report
  • March 2014
  • by Infiniti Research Limited

About Diabetic Nephropathy Diabetic nephropathy is a disease of the kidney glomerulus, which is caused by high blood sugar. When diabetes damages kidneys, which contain millions of tiny blood vessel clusters ...

  • Industries : Pathology
  • Countries : World
Chronic Myelocytic Leukemia (CML, Chronic Myeloid Leukemia) Global Clinical Trials Review, H1, 2014

Chronic Myelocytic Leukemia (CML, Chronic Myeloid Leukemia) Global Clinical Trials Review, H1, 2014

  • $ 2 500
  • Industry report
  • March 2014
  • by Global Data

Chronic Myelocytic Leukemia (CML, Chronic Myeloid Leukemia) Global Clinical Trials Review, H1, 2014 Summary GlobalData's clinical trial report, “Chronic Myelocytic Leukemia (CML, Chronic Myeloid Leukemia) ...

  • Industries : Pathology
  • Countries : World
Diffuse Large B-Cell Lymphoma Global Clinical Trials Review, H1, 2014

Diffuse Large B-Cell Lymphoma Global Clinical Trials Review, H1, 2014

  • $ 2 500
  • Industry report
  • February 2014
  • by Global Data

Diffuse Large B-Cell Lymphoma Global Clinical Trials Review, H1, 2014 Summary GlobalData's clinical trial report, “Diffuse Large B-Cell Lymphoma Global Clinical Trials Review, H1, 2014" provides data ...

  • Industries : Pathology
  • Countries : World
Cutaneous T-Cell Lymphoma Global Clinical Trials Review, H1, 2014

Cutaneous T-Cell Lymphoma Global Clinical Trials Review, H1, 2014

  • $ 2 500
  • Industry report
  • February 2014
  • by Global Data

Cutaneous T-Cell Lymphoma Global Clinical Trials Review, H1, 2014 Summary GlobalData's clinical trial report, “Cutaneous T-Cell Lymphoma Global Clinical Trials Review, H1, 2014" provides data on the ...

  • Industries : Pathology
  • Countries : World
B-Cell Chronic Lymphocytic Leukemia Global Clinical Trials Review, H1, 2014

B-Cell Chronic Lymphocytic Leukemia Global Clinical Trials Review, H1, 2014

  • $ 2 500
  • Industry report
  • February 2014
  • by Global Data

B-Cell Chronic Lymphocytic Leukemia Global Clinical Trials Review, H1, 2014 Summary GlobalData's clinical trial report, “B-Cell Chronic Lymphocytic Leukemia Global Clinical Trials Review, H1, 2014" provides ...

  • Industries : Pathology
  • Countries : World
AIDS - Related Lymphoma Global Clinical Trials Review, H1, 2014

AIDS - Related Lymphoma Global Clinical Trials Review, H1, 2014

  • $ 2 500
  • Industry report
  • February 2014
  • by Global Data

AIDS - Related Lymphoma Global Clinical Trials Review, H1, 2014 Summary GlobalData's clinical trial report, “AIDS - Related Lymphoma Global Clinical Trials Review, H1, 2014" provides data on the AIDS ...

  • Industries : Pathology
  • Countries : World
Basal Cell Carcinoma (Basal Cell Epithelioma) Global Clinical Trials Review, H1, 2014

Basal Cell Carcinoma (Basal Cell Epithelioma) Global Clinical Trials Review, H1, 2014

  • $ 2 500
  • Industry report
  • February 2014
  • by Global Data

Basal Cell Carcinoma (Basal Cell Epithelioma) Global Clinical Trials Review, H1, 2014 Summary GlobalData's clinical trial report, “Basal Cell Carcinoma (Basal Cell Epithelioma) Global Clinical Trials ...

  • Industries : Pathology
  • Countries : World
AIDS - Related Cancer Global Clinical Trials Review, H1, 2014

AIDS - Related Cancer Global Clinical Trials Review, H1, 2014

  • $ 2 500
  • Industry report
  • February 2014
  • by Global Data

AIDS - Related Cancer Global Clinical Trials Review, H1, 2014 Summary GlobalData's clinical trial report, “AIDS - Related Cancer Global Clinical Trials Review, H1, 2014" provides data on the AIDS - Related ...

  • Industries : Pathology
  • Countries : World
Angioimmunoblastic T-Cell Lymphoma (AILT)/Immunoblastic Lymphadenopathy Global Clinical Trials Review, H1, 2014

Angioimmunoblastic T-Cell Lymphoma (AILT)/Immunoblastic Lymphadenopathy Global Clinical Trials Review, H1, 2014

  • $ 2 500
  • Industry report
  • February 2014
  • by Global Data

Angioimmunoblastic T-Cell Lymphoma (AILT)/Immunoblastic Lymphadenopathy Global Clinical Trials Review, H1, 2014 Summary GlobalData's clinical trial report, “Angioimmunoblastic T-Cell Lymphoma (AILT)/Immunoblastic ...

  • Industries : Pathology
  • Countries : World, United States
B-Cell Lymphomas Global Clinical Trials Review, H1, 2014

B-Cell Lymphomas Global Clinical Trials Review, H1, 2014

  • $ 2 500
  • Industry report
  • February 2014
  • by Global Data

B-Cell Lymphomas Global Clinical Trials Review, H1, 2014 Summary GlobalData's clinical trial report, “B-Cell Lymphomas Global Clinical Trials Review, H1, 2014" provides data on the B-Cell Lymphomas ...

  • Industries : Pathology
  • Countries : World
2014 Deep Research Report on Global and China Breast Localization Wire Industry

2014 Deep Research Report on Global and China Breast Localization Wire Industry

  • $ 2 200
  • Industry report
  • March 2014
  • by QY Research Group

Summary "2014 Deep Research Report on Global and China Breast Localization Wire Industry" was professional and depth research report on Global and China Breast Localization Wire industry. The report firstly ...

  • Industries : Pathology
  • Countries : China, World
World Therapy: Glomerulonephritis – Pipeline Review, H1 2012

World Therapy: Glomerulonephritis – Pipeline Review, H1 2012

  • $ 2 000
  • Industry report
  • March 2014
  • by Global Markets Direct

This report provides data on the therapeutic development for Glomerulonephritis, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players ...

  • Industries : Pathology
  • Countries : China, World

» View Public Reports

About 1 500 reports

Pharmaceutical Sector in Denmark

  • Industry report
  • April 2014
  • 23 pages
  • by Intergovernmental Agency

... Standardised to the who european standard population although mortality rates for typ. Chronic diseases vary largely, eastern european countries show significant higher motality rates as compared to southern ...


» Read our Company Profiles

89 Companies

Novartis Inc.

Switzerland

GlaxoSmithKline P.L.C.

United States

GlaxoSmithKline PLC

United Kingdom

Eli Lilly and Co.

United States

Lilly and Co.

United States

ReportLinker is a professional search engine that provides an easy access to 1,2 million market research reports and industry statistics published by 200,000 authoritative sources.